178 related articles for article (PubMed ID: 37969817)
1. Comparison of transarterial bland embolization and drug-eluting beads transarterial chemoembolization for very early and early hepatocellular carcinoma not amenable for surgery or ablation: a single center retrospective data analysis.
Cathomas M; Mueller F; Mertineit N; Baumgartner I; Candinas D; Berzigotti A; Maurer MH; Lachenmayer A
J Gastrointest Oncol; 2023 Oct; 14(5):2167-2177. PubMed ID: 37969817
[TBL] [Abstract][Full Text] [Related]
2. Comparison of initial tumor responses to transarterial bland embolization and drug-eluting beads-transarterial chemoembolization in the management of hepatocellular carcinoma: a propensity-score matching analysis.
Guo J; Wang W; Zhang Y; Xu L; Kong J
J Gastrointest Oncol; 2021 Aug; 12(4):1838-1850. PubMed ID: 34532132
[TBL] [Abstract][Full Text] [Related]
3. Comparative effectiveness of different transarterial embolization therapies alone or in combination with local ablative or adjuvant systemic treatments for unresectable hepatocellular carcinoma: A network meta-analysis of randomized controlled trials.
Katsanos K; Kitrou P; Spiliopoulos S; Maroulis I; Petsas T; Karnabatidis D
PLoS One; 2017; 12(9):e0184597. PubMed ID: 28934265
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the Treatment Response of Drug-Eluting Bead Transarterial Chemoembolization and Conventional Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma.
Adel H; Shazlee MK; Qamar S; Hyder SMS; Razaque A
Cureus; 2023 Jul; 15(7):e41701. PubMed ID: 37575777
[TBL] [Abstract][Full Text] [Related]
5. Radiofrequency vs Microwave Ablation After Neoadjuvant Transarterial Bland and Drug-Eluting Microsphere Chembolization for the Treatment of Hepatocellular Carcinoma.
Thornton LM; Cabrera R; Kapp M; Lazarowicz M; Vogel JD; Toskich BB
Curr Probl Diagn Radiol; 2017; 46(6):402-409. PubMed ID: 28392205
[TBL] [Abstract][Full Text] [Related]
6. Survival and Outcome in Patients Receiving Drug-Eluting Beads Transarterial Chemoembolization for Large Hepatocellular Carcinoma (>5 cm).
Mukund A; Bhardwaj K; Choudhury A; Sarin SK
J Clin Exp Hepatol; 2021; 11(6):674-681. PubMed ID: 34866846
[TBL] [Abstract][Full Text] [Related]
7. Comparison of lipiodol infusion and drug-eluting beads transarterial chemoembolization of hepatocellular carcinoma in a real-life setting.
Karalli A; Teiler J; Haji M; Seth E; Brismar TB; Wahlin S; Axelsson R; Stål P
Scand J Gastroenterol; 2019 Jul; 54(7):905-912. PubMed ID: 31287338
[No Abstract] [Full Text] [Related]
8. Effectiveness of drug-eluting bead transarterial chemoembolization versus conventional transarterial chemoembolization for small hepatocellular carcinoma in Child-Pugh class A patients.
Lee IJ; Lee JH; Lee YB; Kim YJ; Yoon JH; Yin YH; Lee M; Hur S; Kim HC; Jae HJ; Chung JW
Ther Adv Med Oncol; 2019; 11():1758835919866072. PubMed ID: 31447948
[TBL] [Abstract][Full Text] [Related]
9. Transarterial chemoembolization using drug-eluting bead compared with radiofrequency ablation for treatment of single small hepatocellular carcinoma: a pilot non-randomized trial.
Kim TH; Kim NH; Kim JD; Kim YN; Kim YJ; Kim EJ; Yoo KD; Ryu CH; Song HH; Kim H
J Liver Cancer; 2021 Sep; 21(2):146-154. PubMed ID: 37383084
[TBL] [Abstract][Full Text] [Related]
10. Oxaliplatin Eluting CalliSpheres Microspheres for the Treatment of Unresectable or Recurrent Hepatocellular Carcinoma.
Bi Y; Ren K; Ren J; Ma J; Han X
Front Pharmacol; 2022; 13():923585. PubMed ID: 36034827
[No Abstract] [Full Text] [Related]
11. Treatment efficacy and safety of drug-eluting beads transarterial chemoembolization versus conventional transarterial chemoembolization in hepatocellular carcinoma patients with arterioportal fistula.
Cai L; Li H; Guo J; Zhao W; Duan Y; Hou X; Cheng L; Du H; Shao X; Diao Z; Hao Y; Zheng X; Li C; Li W
Cancer Biol Ther; 2022 Dec; 23(1):89-95. PubMed ID: 35230928
[TBL] [Abstract][Full Text] [Related]
12. Transarterial embolization is an acceptable bridging therapy to hepatocellular carcinoma prior to liver transplantation.
Lazzarotto-da-Silva G; Scaffaro LA; Farenzena M; Prediger L; Silva RK; Feier FH; Grezzana-Filho TJM; Rodrigues PD; de Araujo A; Alvares-da-Silva MR; Marchiori RC; Kruel CRP; Chedid MF
World J Transplant; 2024 Jun; 14(2):90571. PubMed ID: 38947974
[TBL] [Abstract][Full Text] [Related]
13. Drug-Eluting Bead Transarterial Chemoembolization Versus Radiofrequency Ablation as an Initial Treatment of Single Small (≤ 3 cm) Hepatocellular Carcinoma.
Lee S; Jeong YY; Lee BC; Shin SS; Heo SH; Kim HO; Park C; Jeong WG
J Korean Med Sci; 2023 Oct; 38(42):e362. PubMed ID: 37904659
[TBL] [Abstract][Full Text] [Related]
14. Transarterial chemoembolization using 40 µm drug eluting beads for hepatocellular carcinoma.
Greco G; Cascella T; Facciorusso A; Nani R; Lanocita R; Morosi C; Vaiani M; Calareso G; Greco FG; Ragnanese A; Bongini MA; Marchianò AV; Mazzaferro V; Spreafico C
World J Radiol; 2017 May; 9(5):245-252. PubMed ID: 28634515
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of transcatheter embolization/chemoembolization (TAE/TACE) for the treatment of single hepatocellular carcinoma.
Miraglia R; Pietrosi G; Maruzzelli L; Petridis I; Caruso S; Marrone G; Mamone G; Vizzini G; Luca A; Gridelli B
World J Gastroenterol; 2007 Jun; 13(21):2952-5. PubMed ID: 17589945
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive predictive factors for CalliSpheres® microspheres (CSM) drug-eluting bead-transarterial chemoembolization and conventional transarterial chemoembolization on treatment response and survival in hepatocellular carcinoma patients.
Chen C; Qiu H; Yao Y; Zhang Z; Ma C; Ma Y; Zhao C; Xiang H; Zhao H; Zheng C; Xiong B; Li H; Long Q; Zhou J; Luo C; Hu H
Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101460. PubMed ID: 32593695
[TBL] [Abstract][Full Text] [Related]
17. Transarterial bland versus chemoembolization for hepatocellular carcinoma: rethinking a gold standard.
Massarweh NN; Davila JA; El-Serag HB; Duan Z; Temple S; May S; Sada YH; Anaya DA
J Surg Res; 2016 Feb; 200(2):552-9. PubMed ID: 26507276
[TBL] [Abstract][Full Text] [Related]
18. Prospective randomized comparison of chemoembolization with doxorubicin-eluting beads and bland embolization with BeadBlock for hepatocellular carcinoma.
Malagari K; Pomoni M; Kelekis A; Pomoni A; Dourakis S; Spyridopoulos T; Moschouris H; Emmanouil E; Rizos S; Kelekis D
Cardiovasc Intervent Radiol; 2010 Jun; 33(3):541-51. PubMed ID: 19937027
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Trans-Arterial Chemoembolization and Bland Embolization for the Treatment of Hepatocellular Carcinoma: A Propensity Score Analysis.
Roth GS; Benhamou M; Teyssier Y; Seigneurin A; Abousalihac M; Sengel C; Seror O; Ghelfi J; Ganne-Carrié N; Blaise L; Sutter O; Decaens T; Nault JC
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33672012
[TBL] [Abstract][Full Text] [Related]
20. Safety, efficacy, and survival of drug-eluting beads-transarterial chemoembolization vs. conventional-transarterial chemoembolization in advanced HCC patients with main portal vein tumor thrombus.
Chen J; Lai L; Zhou C; Luo J; Wang H; Li M; Huang M
Cancer Imaging; 2023 Jul; 23(1):70. PubMed ID: 37481660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
